Kiniksa Pharmaceuticals Intern
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Kiniksa Pharmaceuticals Intern COM, CUSIP G5269C101.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for Kiniksa Pharmaceuticals Intern COM, CUSIP G5269C101.